From: Risk factors for complications and mortality of percutaneous endoscopic gastrostomy insertion
 | Total (n = 401) | Pull type (n = 139) | Introducer type (n = 262) | p value |
---|---|---|---|---|
Clinical characteristics | ||||
 Age (median, IQR) | 68 (57–77) | 67 (55–76) | 70 (57–77) | 0.404 |
 Gender, male (%) | 262 (65.3) | 82 (59) | 180 (68.7) | 0.052 |
 BMI (median, IQR) | 19.5 (17.2–21.7) | 20.1 (17.3–23.0) | 19.3 (17.1–21.2) | 0.017 |
Indications for PEG, n (%) | ||||
 Neurologic disease | 240 (59.8) | 85 (61.2) | 155 (59.2) | 0.645 |
 Malignancy | 70 (17.4) | 29 (20.8) | 41 (15.7) | 0.190 |
 Other | 91 (22.7) | 25 (18.0) | 66 (25.2) | 0.086 |
Comorbidities (%) | 212 (52.9) | 77 (55.4) | 135 (51.5) | 0.460 |
Antibiotic prophylaxis, n (%) | 377 (94.0) | 124 (89.2) | 253 (96.6) | 0.003 |
Concurrent medication, n (%) | ||||
 Aspirin | 63 (15.7) | 26 (18.7) | 37 (14.1) | 0.230 |
 Clopidogrel | 26 (6.5) | 10 (7.2) | 16 (6.1) | 0.674 |
 Warfarin | 12 (3.0) | 4 (2.9) | 8 (3.1) | 0.922 |
 Others | 23 (5.7) | 8 (5.8) | 15 (5.7) | 0.990 |
Laboratory values | ||||
 WBC/μL | 8243.0 ± 3580.2 | 8083.4 ± 3809.8 | 8324.6 ± 3461.6 | 0.528 |
 Hemoglobin, g/dL | 11.2 ± 2.0 | 11.2 ± 1.9 | 11.2 ± 2.0 | 0.987 |
 Platelets, × 103/μL | 266.1 ± 119.1 | 276.5 ± 137.7 | 260.8 ± 108.3 | 0.216 |
 Albumin, g/dL | 3.0 ± 0.7 | 3.0 ± 0.6 | 3.0 ± 0.7 | 0.925 |
 Prothrombin time, INR | 1.06 ± 0.27 | 1.03 ± 0.27 | 1.07 ± 0.27 | 0.826 |
 CRP, mg/dL | 3.0 ± 3.9 | 3.4 ± 4.4 | 2.9 ± 3.7 | 0.283 |